|

Orca-Q Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Florida1

Indications

  • Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis)1
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis1
  • Acute Lymphoid Leukemia1
  • Mixed Phenotype Acute Leukemia1
  • Acute Undifferentiated Leukemia1

Gainesville, Florida1 trial

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

University of Florida

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.